Heparin medication monitoring system

Abstract

The invention provides a heparin medication monitoring system which is characterized by mainly comprising a data acquisition part, a time judgment setting part, an adjustment method setting part, a target dosage calculation part and a dosage conversion part, wherein the time judgment setting part judges a corresponding time interval according to the activated partial thromboplastin time or the activated thromboplastin time acquired by the data acquisition part and sets the time interval as a specific time interval; the adjustment method setting part sets a dosage adjustment method corresponding to the specific time interval as a target dosage adjustment method; and the target dosage calculation part calculates the target dosage according to the target dosage adjustment method and the historical dosage, and the dosage conversion part converts the target dosage and the weight of a patient according to a dosage calculation rule to obtain a to-be-injected dosage. According to the system, medical staff can accurately know the condition of the patient in real time, reference related to heparin medication adjustment is provided for the medical staff, medication conversion time can be saved, and the problem of conversion errors caused by shift change is avoided.

Description

technical field [0001] The invention specifically relates to a heparin medication monitoring system. Background technique [0002] ECMO, as a cardio / pulmonary assistance method, is widely used in the end-stage of various types of cardiogenic shock, heart failure, and ARDS caused by various reasons. Thrombotic events are a well-known complication of ECMO and one of the main reasons for ECMO failure, with an incidence rate as high as 50%. Therefore, how to prevent the formation of thrombus due to the contact of blood with a large amount of foreign body surfaces in clinical practice has become a problem of great concern to both patients and medical staff. [0003] Heparin is the most common anticoagulant drug used to prevent thrombosis in ECMO, and the metabolism of heparin varies greatly in different patients, and the metabolism is poorly correlated with the dose of heparin, so it is impossible to predict the effect of heparin, so close monitoring of heparin is required. Ant...

AI Technical Summary

Problems solved by technology

When the two doctors take over the shift, the current doctor needs to adjust the heparin dosage based on the mg conversion in the doctor's order to get U. There may be a problem of manual calculation errors, which will endanger the lives of patients using ECMO.

Images